References

1. Brook I, Yocum P, Friedman EM. Aerobic and anaerobic flora recovered from tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol 1981; 90:261-3.

2. Brook I, Yocum P. Comparison of the microbiology of group A streptococcal and non-group A streptococcal tonsillitis. Ann Otol Rhinol Laryngol 1988; 97:243-6.

3. Brook I, Yocum P. Bacteriology of chronic tonsillitis in young adults. Arch Otolaryngol 1984; 110:803-5.

4. Brook I. Aerobic and anaerobic bacteriology of peritonsillar abscess in children. Acta Paediatr Scand 1981; 70:831-5.

5. Reilly S, Timmis P, Beeden AG, Willis AT. Possible role of the anaerobe in tonsillitis. J Clin Pathol 1981; 34:542-7.

6. Chagollan JJ, Ramirez MJ, Gil JS. Flora indigena de las amigdalas. Invest Med Int 1984; 11:36-44.

7. Rosen G, Samuel J, Vered I. Surface tonsillar microflora versus deep tonsillar microflora in recurrent tonsillitis. J Laryngol Otol 1977; 91:911-3.

8. Brodsky L, Nagy M, Volk M, Stanievich J, Moore L. The relationship of tonsil bacterial concentration to surface and core cultures in chronic tonsillar disease in children. Int J Pediatr Otorhinolaryngol 1991; 21:33-9.

9. Brook I, Yocum P, Shah K. Surface vs. core-tonsillar aerobic and anaerobic flora in recurrent tonsillitis. JAMA 1980; 244:169-86.

10. Mitchelmore IJ, Reilly PG, Hay AJ, Tabaqchali S. Tonsil surface and core cultures in recurrent tonsillitis: prevalence of anaerobes and beta-lactamase producing organisms. Eur J Clin Microbiol Infect Dis 1994; 13:542-8.

11. Brook I, Gober AE. Interference by aerobic and anaerobic bacteria in children with recurrent group A beta-hemolytic streptococcal tonsillitis. Arch Otolaryngal Head Neck Surg 1999; 125: 225-554.

12. Brook I, Yocum P, Foote PA. Changes in the core tonsillitis bacteriology of recurrent tonsillitis: 1977-1993. Clin Infect Dis 1995; 21:171-6.

13. Tuner K, Nord CE. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis 1983; 39(Suppl.):83-5.

14. Kielmovitech IH, Keltel G, Bluestone C, et al. Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis. Arch Otolaryngol Head Neck Surg 1989; 115:721-5.

15. Brook I, Foote PA. Comparison of the microbiology of recurrent tonsillitis between children and adults. Laryngoscope 1986; 93:1385-8.

16. Kuhn JJ, Brook I, Waters CL, Church LW, Bianchi DA, Thompson DH. Quantitative bacteriology of tonsils removed from children with tonsillitis hypertrophy and recurrent tonsillitis with and without hypertrophy. Ann Otol Rhinol Laryngol 1995; 104:646-52.

17. Sclafani AP, Ginsburg J, Shah MK, Dolisky JN. Treatment of symptomatic chronic adenotonsillar hypertrophy with amoxicillin/clavulanate potassium: short- and long-term results. Pediatrics 1998; 101:675-81.

18. Brook I. Anaerobic bacteria in upper respiratory tract and other head and neck infections. Ann Otol Rhinol Laryngol 2002; 111:430-40.

19. Pransky SM, Feldman JI, Kearns DB, Seid AB, Billman GF. Actinomycosis in abstructive tonsillar hypertrophy and recurrent tonsillitis. Arch Otolaryngol Head Neck Surg 1991; 117:883-5.

20. Socransky SS, Manganiello SD. The oral microbiota of man from birth to senility. J Periodontol 1971; 42:485-96.

21. Brook I. Anaerobic infections in children. Microbes Infect 2002; 4:1271-80.

22. Brook I, Foote PA, Jr. Microbiology of "normal" tonsils. Ann Otol Rhinol Laryngol 1990; 99:980-3.

23. Brook I. Microbiology of retropharyngeal abscesses in children. Am J Dis Child 1987; 141:202-3.

24. Folayan MO. The epidemiology, etiology, and pathophysiology of acute necrotizing ulcerative gingivitis associated with malnutrition. J Contemp Dent Pract 2004; 5:28-41.

25. Brook I, Gober AE. Bacteroides melaninogenicus: its recovery from tonsils of children with acute tonsillitis. Arch Otolaryngol 1984; 109:818-21.

26. Davidson S, Kaplinsky C, Frand M, Rotem J. Treatment of infectious mononucleosis with metronidazole in the pediatric age group. Scand J Infect Dis 1982; 14:103-4.

27. Helstrom SA, Mandl PA, Ripa T. Treatment of anginose mononucleosis with metronidazole. Scand J Infect Dis 1978; 10:7-9.

28. McDonald CJ, Tierney WM, Hui SL. A controlled trial of erythromycin in adults with non streptococcal pharyngitis. J Infect Dis 1985; 152:1093-4.

29. Merenstein JH, Rogers KD. Streptococcal pharyngitis: early treatment and management by nurse practitioners. JAMA 1974; 227:1278-82.

30. Putto A. Febrile exudative tonsillitis: viral or streptococcal. Pediatrics 1987; 80:6-12.

31. Brook I. Medical treatment of non-streptococcal recurrent tonsillitis. Am J Otolaryngol 1989; 10:227-33.

32. Brook I, Gillmore JD, Coolbaugh JC, Walker RI. Pathogenicity of encapsulated Bacteroides melaninogenicus group, Bacteroides oralis, and Bacteroides ruminicola in abscesses in mice. J Infect 1983; 7:218-26.

33. Brook I, Foote PA, Jr., Slots J, Jackson W. Immune response to Prevotella intermedia in patients with recurrent non-streptococcal tonsillitis. Ann Otol Rhinol Laryngol 1993; 102:113-6.

34. Brook I, Foote PA, Slots J. Immune response to Fusobacterium nucleatum, Prevotella intermedia and other anaerobes in children with acute tonsillitis. J Antimicrob Chemother 1997; 39:763-9.

35. Brook I, Foote PA, Slots J. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with peritonsillar cellulitis and abscess. Clin Infect Dis 1995; 20:S220-1.

36. Brook I, de Leyva F. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with infectious mononucleosis. J Med Microbiol 1996; 44:131-4.

37. Brook I, de Leyva F. Microbiology of tonsillar surfaces in infectious mononucleosis. Arch Pediatr Adolesc Med 1994; 148:171-3.

38. Brook I, Gober AE. Treatment of non-streptococcal tonsillitis with metronidazole. Int J Pediatr Otorhinolaryngol 2005; 69:65-8.

39. Smith TD, Huskins WC, Kim KS, Kaplan EL. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin in eradicating streptococci for the pharynx after failure of penicillin therapy for Group A streptococcal pharyngitis. J Pediatr 1987; 110:777-82.

40. Pichichero ME, Green JL, Francis AB, et al. Recurrent group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 1998; 17:809-15.

41. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6:601-7.

42. Brook I, Yocum P. Quantitative measurement of beta-lactamase levels in tonsils of children with recurrent tonsillitis. Acta Otolaryngol 1984; 98:556-60.

43. Brook I, Yocum P. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis. Chemotherapy 1983; 29:18-23.

44. Simon HJ, Sakai W. Staphylococcal antagonism to penicillin group therapy of hemolytic streptococcal pharyngeal infection effect of oxacillin. Pediatrics 1963; 31:463-9.

45. Scheifele DW, Fussell SJ. Frequency of ampicillin resistant Haemophilus parainfluenzae in children. J Infect Dis 1981; 143:495-8.

46. Hackman AS, Wilkins TD. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis. Antimicrob Agents Chemother 1975; 7:698-703.

47. Hackman AS, Wilkins TD. Influence of penicillinase production by strains of Bacteroides melanino-genicus and Bacteroides oralis on penicillin therapy of an experimental mixed anaerobic infection in mice. Arch Oral Biol 1976; 21:385-9.

48. Brook I, Pazzaglia G, Coolbaugh JC, Walker RI. In vivo protection of group A beta hemolytic streptococci from penicillin by beta lactamase producing bacteroides species. J Antimicrob Chemother 1983; 12:599-606.

49. Brook I, Gober AE. Emergence of beta lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clin Pediatr 1984; 23:338-41.

50. Tuner K, Nord CE. Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment. Eur J Clin Microb 1986; 5:399-404.

51. Brook I. Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg 1988; 114:667-70.

52. Brook I. Role of beta lactamase-producing bacteria in penicillin failure to eradicate group A streptococci. Pediatric Infect Dis 1985; 4:491-5.

53. Roos K, Grahn E, Holm SE. Evaluation of beta lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis 1986; 18:313-9.

54. Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness: comparison of lincomycin, ampicillin, and potassium penicillin in treatment. Am J Dis Child 1966; 112:21-7.

55. Orrling A, Stjernquist-Desatnik A, Schalen C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 1994; 26:535-41.

56. Breese BB, Disney FA, Talpey WB, Green J. Beta-hemolytic streptococcal infection: comparison of penicillin and lincomycin in the treatment of recurrent infections of the carrier state. Am J Dis Child 1969; 117:147-52.

57. Massell BF. Prophylaxis of streptococcal infection and rheumatic fever: a comparison of orally administered clindamycin and penicillin. JAMA 1979; 241:1589-94.

58. Randolph MF, DeHaan RM. A comparison of lincomycin and pencillin in the treatment of group A streptococcal infection. Del Med J 1969; 41:51-62.

59. Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis: III. Streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorolincomycin). Del Med J 1970; 42:87-92.

60. Brook I, Hirokawa R. Treatment of patients with a history of recurret tonsillitis due to group A beta-hemolytic streptococci. Clin Pediatr 1985; 24:331-6.

61. Howie VM, Plousard JH. Treatment of group A streptococcal pharyngitis in children: comparison of lincomycin and penicillin G given orally and benzathine penicillin G given intramuscularly. Am J Dis Child 1971; 121:477-80.

62. Stillerman M, Isenberg HD, Facklam RR. Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin. Antimicrob Agents Chemother 1973; 4:514-20.

63. Brook I. Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium. J Antimicrob Chemother 1989; 24:227-33.

64. Tanz RR, Shulman ST, Barthel MJ, Willert C, Yogev R. Penicillin plus rifampin eradicate pharyngeal carrier of group A streptococci. J Pediatr 1985; 106:876-80.

65. Chaudhary S, Bilinsky SA, Hennessy JL, et al. Penicillin Vand rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs. 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr 1985; 106:481-6.

66. Tanz RR, Poncher JR, Corydon KE, Kabat K, Yogev R, Shulman ST. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 1991; 119:123-8.

67. Brook I, Leyva F. The treatment of the carrier state of group A beta hemolytic streptococci with clindamycin. Chemotherapy 1981; 27:360-7.

68. Brook I. The presence of beta-lactamase-producing bacteria as a guideline in the management of children with recurrent tonsillitis. Am J Otolaryngol 1984; 5:382-6.

69. Foote PA, Jr., Brook I. Penicillin and clindamycin therapy in recurrent tonsillitis. Arch Otolaryngol Head Neck Surg 1989; 116:856-9.

70. Tanz RR, Shulman ST, Sroka PA, Marubio S, Brook I, Yogev R. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr 1990; 117:859-63.

71. Dykhuizen RS, Golder D, Reid TM, Gould IM. Phenoxymethyl penicillin versus co-amoxiclav in the treatment of acute streptococcal pharyngitis, and the role of beta-lactamase activity in saliva. J Antimicrob Chemother 1996; 37:133-8.

72. Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 2004; 113:866-82.

73. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997; 16:680-95.

74. Cizman M, Pokorn M, Seme K, Paragi M, Orazem A. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. Eur J Clin Microbiol Infect Dis 1999; 18:522-4.

75. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337:441-6.

76. Green MD, Beall B, Marcon MJ, et al. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the U.S.A. J Antimicrob Chemother 2006; 57:1240-3.

77. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002; 346:1200-6.

78. Finegold SM. Anaerobic Bacteria in Human Diseases. New York: Academic Press, 1977.

79. Irigoyen MM, Katz M, Larsen JG. Post-anginal sepsis in adolescence. Pediatr Infect Dis 1983; 2:247-50.

80. Shank GD, Berman JD. Anaerobic pulmonary abscesses: hematogenous spread from head and neck infections. Clin Pediatr 1986; 25:520-2.

81. Goldhagen J, Alford BA, Prewitt LH, Thompson L, Hostetter MK. Suppurative thrombophlebitis of the internal jugular vein: report of three cases and review of the pediatric literature. Pediatr Infect Dis J 1988; 7:410-4.

82. Golpe R, Marin B, Alonso M. Lemierre's syndrome (necrobacillosis). Postgrad Med J 1999; 75:141-4.

83. Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis 1996; 23:S97-101.

84. Brook I. Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. J Infect Dis 1989; 160:1071-5.

85. Veltri RW, Sprinkle PM, Keller SA, Chicklo JM. Ecological alterations of oral microflora subsequent to tonsillectomy and adenoidectomy. J Laryngol Otol 1972; 86:893-903.

86. Huminer D, Pitlik S, Levy R, Samra Z. Mycoplasma and Chlamydia in adenoids and tonsils of children undergoing adenoidectomy or tonsillectomy. Ann Otol Rhinol Laryngol 1994; 103:135-8.

87. Tomonaga K, Kurono Y, Chaen T, Mogi G. Adenoids and otitis media with effusion: nasopharyngeal flora. Am J Otolaryngol 1989; 10:204-7.

88. Bernstein JM, Reddy MS, Scannapieco FA, Faden HS, Ballow M. The microbial ecology and immunology of the adenoid: implications for otitis media. Ann N Y Acad Sci 1997; 830:19-31.

89. Gates GA, Avery CA, Prihoda TJ, Cooper JC. Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion. N Engl J Med 1987; 317:1444-51.

90. Gates GA, Avery CA, Prihoda TJ. Effect of adenoidectomy upon children with chronic otitis media with effusion. Laryngoscope 1988; 98:58-63.

91. Fujita A, Takahashi H, Honjo I. Etiological role of adenoids upon otitis media with effusion. Acta Otolaryngol Stockh 1988; 454:210-3.

92. Fukuda K, Matsune S, Ushikai M, Imaura Y, Ohyama M. A study of the relationship between adenoid vegetation and rhinosinusitis. Am J Otolaryngol 1989; 10:214-6.

93. Wilson TG. The aetiology of chronic rhinitis and sinusitis in children. Laryngol Otol 1965; 79:365-83.

94. Fearon M, Bannatyne RM, Fearon BW, Turner A, Cheung R. Differential bacteriology in adenoid disease. J Otolaryngol 1992; 21:434-6.

95. Klein GL, Timms R, Ziering RW. Obstructive sleep apnea presenting as mouth breathing in a five year old. Immunol Allergy Pract 1984; 6:59-61.

96. Schiffman R, Faber J, Eidelman AL. Obstructive hypertrophic adenoids and tonsils as a cause of infantile failure to thrive: reversed by tonsillectomy and adenoidectomy. Int J Pediatr Otorhinolar-yngol 1985; 9:183-7.

97. Brook I. Aerobic and anaerobic bacteriology of adenoids in children: a comparison between patients with chronic adenotonsillitis and adenoid hypertrophy. Laryngoscope 1980; 91:377-82.

98. Brook I, Shah K, Jackson W. Microbiology of healthy and diseased adenoids. Laryngoscope 2000; 110:994-9.

99. Brook I, Shah K. Bacteriology of adenoids and tonsils in children with recurrent adeno-tonsillitis. Ann Otol Rdinol Laryngol 2001; 110:844-8.

100. Paradise JL, Bluestone CD, Colborn DK, et al. Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not previously treated with tympanostomy tubes. JAMA 1999; 282:945-53.

101. Marchant CD, Collison LM. Serous and recurrent otitis media. Pharmacological or surgical management? Drugs 1987; 34:695-701.

102. Levine MK, Beman JD. A comparison of clindamycin and erythromycin in beta-hemolytic streptococcal infections. J Med Assoc Ga 1972; 6:108-11.

103. Mackie PL. The classification of viruses infecting the respiratory tract. Paediatr Respir Rev 2003; 4:84-90.

104. Brook I, Gober AE. Dynamics of nasopharyngitis in children. Otolaryngol Head Neck Surg 2000; 122:696-700.

105. Brook I. Aerobic and anaerobic bacteriology of purulent nasopharyngitis in children. J Clin Microbiol 1988; 26:592-4.

106. Todd JK, Todd N, Damato J, Todd WA. Bacteriology and treatment of purulent nasopharyngitis: a double blind, placebo-controlled evaluation. Pediatr Infect Dis 1984; 3:226-32.

107. Sanders SS, Nelson GE, Sanders WE, Jr. Bacterial interference IV. Epidemiological determinants of the antagonistic activity of the normal flora against group A streptococci. Infect Immun 1977; 16:599-606.

108. Sprunt K, Redman W. Evidence suggesting importance of role of interbacterial inhibition in maintaining a balance of normal flora. Ann Intern Med 1968; 68:579-87.

109. Bernstein JM, Sagahtaheri-Altaie S, Dryjd DM, Wactawski-Wende J. Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-otitis-prone children. Acta Otorhinolaryngol Belg 1994; 48:1-9.

110. Murray PR, Rosenblatt JE. Bacterial interference by oropharyngeal and clinical isolates of anaerobic bacteria. J Infect Dis 1976; 134:281-5.

111. Faden H, Zaz MJ, Bernstein JM, Brodsky L, Stanievich J, Ogra PL. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhin Laryngol 1991; 100:612-5.

112. Feigin RD, Cherry JD. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia: WB Saunders Company, 2004.

113. Butterton JR, Clawson-Simons J. Hymenoptera uvulitis. N Engl J Med 1987; 317:1291.

114. DeNavasquez S. Acute laryngitis and septicemia due to H. influenzae type b. Br Med J 1942; 2:187-8.

115. Li KI, Kiernan S, Wald ER. Isolated uvulitis due to Haemophilus influenzae type b. Pediatrics 1984; 74:1054-7.

116. Wynder SG, Lampem RM, Shoemaker ME. Uvulitis and Haemophilus influenzae b bacteremia. Pediatr Emerg Care 1986; 2:23-5.

117. Brook I. Uvulitis caused by anaerobic bacteria. Pediatr Emerg Care 1997; 13:221.

118. Gorfinkel HJ, Brown R, Kabins SA. Acute infectious epiglottitis in adults. Ann Intern Med 1969; 70:289-94.

119. Kotloff KL, Wald ER. Uvulitis in children. Pediatr Infect Dis 1983; 2:392-3.

How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book


Post a comment